HIV drug resistance occurs when the human immunodeficiency virus develops changes that reduce the effectiveness of certain medicines used to control it. Resistance can make treatment less effective and allow the virus to multiply, potentially affecting long term health. Understanding how resistance develops.
HIV treatment involves antiretroviral therapy, commonly called ART, which uses a combination of medicines to prevent the virus from multiplying. These medicines target different stages of the viral life cycle. When a treatment regimen works effectively, it can reduce the amount of HIV in the blood to an undetectable level. However, drug resistance can develop when the virus acquires genetic changes that reduce its susceptibility to particular medications. Resistance does not mean that all HIV medicines have stopped working. Instead, healthcare professionals assess the available treatment options and determine whether adjustments are necessary.
HIV reproduces rapidly and can develop genetic variations during replication. Some variations allow the virus to continue multiplying despite the presence of particular antiretroviral medicines. When these resistant variants become established, one or more drugs in a treatment regimen may become less effective.
Several factors can contribute to the development of drug resistance. Inconsistent medication use, interruptions in treatment, interactions with other medicines, and an inadequately effective treatment regimen may allow HIV to multiply while exposed to drug concentrations that do not fully suppress it. Resistance can also be transmitted when a person acquires HIV that already carries resistant variants.
Important aspects of HIV drug resistance include:
Medication adherence: Taking prescribed medicines according to the treatment plan helps maintain effective drug levels and reduce the risk of resistance.
Viral load changes: A viral load that rises after previously being suppressed may indicate treatment failure, although other explanations must also be considered.
Resistance testing: Genotypic testing can identify certain genetic changes associated with resistance to specific HIV medicines.
Drug interactions: Some prescription medicines, nonprescription products, and supplements can affect antiretroviral drug levels.
Treatment interruptions: Stopping or repeatedly missing medicines without medical guidance can increase the risk of viral rebound and, in some circumstances, resistance.
Resistance testing is particularly useful when treatment is not working as expected. The timing and type of testing depend on the person's treatment history, viral load, and clinical circumstances. A healthcare professional may also review previous resistance results before selecting a new regimen.
Treatment changes may be considered when viral suppression is not achieved or maintained, side effects become difficult to manage, drug interactions occur, or resistance reduces the effectiveness of the current regimen. Clinicians evaluate these factors alongside a person's medical history, previous treatments, and available medicines.
Common considerations when reviewing HIV treatment include:
Viral load monitoring: Blood tests measure the amount of HIV in the bloodstream and help determine whether treatment is controlling the virus.
Resistance test results: Identifying resistant variants helps clinicians select medicines that are likely to remain effective.
Treatment history: Previous regimens, missed doses, and earlier resistance findings can influence the next treatment choice.
Medication tolerability: Side effects and interactions may require a different combination of medicines.
Continued follow up: Regular appointments help assess treatment response, monitor potential adverse effects, and address difficulties with medication use.
People should not stop, switch, or change the dose of HIV medicines without consulting their healthcare professional. An appropriate replacement regimen generally needs to account for resistance patterns and include enough fully active medicines to control the virus.
HIV drug resistance is a manageable clinical challenge, although it requires careful assessment and ongoing monitoring. Consistent adherence to prescribed treatment, timely viral load testing, and communication with healthcare professionals can help identify problems early. When treatment changes are needed, an individualized approach can support renewed viral suppression and long term health. Antiretroviral therapy remains a central part of HIV care, and effective treatment can help people living with HIV lead long and healthy lives.